147 related articles for article (PubMed ID: 30407096)
1. Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasone.
Yang H; Zhao H; Huang X; Cao X; Zhou D; Li J
Leuk Lymphoma; 2019 Feb; 60(2):483-487. PubMed ID: 30407096
[TBL] [Abstract][Full Text] [Related]
2. Endocrine Evaluation in POEMS Syndrome: A Cohort Study.
Yang H; Zhao H; Gao X; Huang X; Cao X; Zhou D; Xia W; Li J
Front Endocrinol (Lausanne); 2020; 11():536241. PubMed ID: 33193075
[TBL] [Abstract][Full Text] [Related]
3. Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
Yang H; Huang X; Cai Q; Wang C; Cao X; Zhou D; Li J
Orphanet J Rare Dis; 2016 Jun; 11(1):80. PubMed ID: 27317315
[TBL] [Abstract][Full Text] [Related]
4. Cereblon expression is a prognostic marker in newly diagnosed POEMS syndrome treated with lenalidomide plus dexamethasone.
Cai QQ; Gao XM; Le J; Zhao H; Cai H; Cao XX; Li J
Ann Hematol; 2021 Jun; 100(6):1547-1552. PubMed ID: 33839882
[TBL] [Abstract][Full Text] [Related]
5. Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
Suichi T; Misawa S; Nagashima K; Sato Y; Iwai Y; Katayama K; Sekiguchi Y; Shibuya K; Amino H; Suzuki YI; Tsuneyama A; Nakamura K; Kuwabara S
Intern Med; 2020 May; 59(9):1149-1153. PubMed ID: 32009091
[TBL] [Abstract][Full Text] [Related]
6. Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.
Nozza A; Terenghi F; Gallia F; Adami F; Briani C; Merlini G; Giordano L; Santoro A; Nobile-Orazio E
Br J Haematol; 2017 Dec; 179(5):748-755. PubMed ID: 29048107
[TBL] [Abstract][Full Text] [Related]
7. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
Front Immunol; 2021; 12():681360. PubMed ID: 34025681
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of POEMS syndrome with lenalidomide and dexamethasone].
Goto A; Iyama S; Sugama Y; Yoshida M; Ibata S; Tatekoshi A; Fujita C; Kikuchi S; Ikeda H; Murase K; Takada K; Kato J; Kobune M
Rinsho Ketsueki; 2019; 60(4):308-313. PubMed ID: 31068561
[TBL] [Abstract][Full Text] [Related]
9. Thyroid function and its clinical significance in POEMS syndrome.
Dun XY; Zhou F; Xi H; Yuan ZG; Hou J
Leuk Lymphoma; 2009 Dec; 50(12):2013-6. PubMed ID: 19863172
[TBL] [Abstract][Full Text] [Related]
10. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
Li J; Huang XF; Cai QQ; Wang C; Cai H; Zhao H; Zhang L; Cao XX; Gale RP; Zhou DB
Am J Hematol; 2018 Jun; 93(6):803-809. PubMed ID: 29603764
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment of POEMS syndrome-associated pulmonary hypertension with lenalidomide and dexamethasone therapy].
Nakamura D; Hayashida M; Kubota K; Matsuura E; Tabuchi T; Arima N; Inoue H; Yoshimitsu M; Ishitsuka K
Rinsho Ketsueki; 2018; 59(5):489-491. PubMed ID: 29877235
[TBL] [Abstract][Full Text] [Related]
12. [Effective treatment of POEMS syndrome accompanied by plasmacytoma with lenalidomide, dexamethasone, and local irradiation].
Takahashi W; Ichikawa M; Okazaki A; Nakamura F; Arai H; Handa T; Nakamura Y; Nakamura Y; Seo S; Sasaki K; Mitani K
Rinsho Ketsueki; 2020; 61(3):262-267. PubMed ID: 32224588
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.
Cheng S; Huang L; Fan W; Liang D; Zhu X; Jiang S; Ge Y
Int Urol Nephrol; 2022 Sep; 54(9):2317-2325. PubMed ID: 35133575
[TBL] [Abstract][Full Text] [Related]
14. POEMS syndrome: a rare cause of exudative ascites and chronic peripheral neuropathy.
Al-Mayoof O; Al Sughaiyer H; Abuomar W; Khan M
BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28637843
[TBL] [Abstract][Full Text] [Related]
15. [POEMS syndrome treated with lenalidomide plus high-dose dexamethasone as a pre-transplant induction therapy].
Matsuura S; Ogusa E; Taguchi J; Imai N; Fujita H; Tomita N; Ishigatsubo Y; Fujisawa S
Rinsho Ketsueki; 2012 Dec; 53(12):2025-8. PubMed ID: 23318971
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.
Cai QQ; Wang C; Cao XX; Cai H; Zhou DB; Li J
Eur J Haematol; 2015 Oct; 95(4):325-30. PubMed ID: 25401269
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.
Royer B; Merlusca L; Abraham J; Musset L; Haroche J; Choquet S; Leleu X; Sebban C; Decaux O; Galicier L; Roussel M; Recher C; Banos A; Guichard I; Brisseau JM; Godmer P; Hermine O; Deplanque G; Facon T; Asli B; Leblond V; Fermand JP; Marolleau JP; Jaccard A
Am J Hematol; 2013 Mar; 88(3):207-12. PubMed ID: 23335406
[TBL] [Abstract][Full Text] [Related]
18. Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
Oyama T; Taoka K; Chiba A; Masamoto Y; Ikemura M; Honda A; Maki H; Kurokawa M
Int J Hematol; 2023 Mar; 117(3):463-467. PubMed ID: 36202948
[TBL] [Abstract][Full Text] [Related]
19. Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Suichi T; Misawa S; Sekiguchi Y; Shibuya K; Nakamura K; Kano H; Aotsuka Y; Otani R; Morooka M; Tsukamoto S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Kuwabara S
Intern Med; 2022; 61(17):2567-2572. PubMed ID: 36047093
[TBL] [Abstract][Full Text] [Related]
20. [A case of POEMS syndrome associated with Waldenström's macroglobulinemia and treated with lenalidomide].
Furuta N; Tashiro Y; Ikeda M; Fujita Y; Okamoto K
Rinsho Shinkeigaku; 2012; 52(3):186-9. PubMed ID: 22453045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]